Treatment of typhoid fever in the 21st century: promises and shortcomings.
about
Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatmentStructure and function of the Salmonella Typhi chimaeric A2B5 typhoid toxinAntimicrobial resistance and management of invasive Salmonella diseaseEpidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella InfectionsQuinolone resistance in absence of selective pressure: the experience of a very remote community in the Amazon forestSensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent.Spatiotemporal transmission and determinants of typhoid and paratyphoid fever in Hongta District, Yunnan Province, China.Genomic signature of multidrug-resistant Salmonella enterica serovar typhi isolates related to a massive outbreak in Zambia between 2010 and 2012Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi ASalmonella Bacteremia Among Children in Central and Northwest Nigeria, 2008-2015.A special case of lower back pain in a 3-year-old girl.The emergence and outbreak of multidrug-resistant typhoid fever in China.Case Series of Imported Enteric Fever at a Referral Center in Tokyo, Japan: Antibiotic Susceptibility and Risk Factors for Relapse.Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure.Risk factors for the development of severe typhoid fever in Vietnam.Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.Limitations of typhoid fever diagnostics and the need for prevention.Abdominal lymphadenopathy: an atypical presentation of enteric fever.Septic arthritis of the hip in a Cambodian child caused by multidrug-resistant Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin treated with ceftriaxone and azithromycin.Mechanisms of resistance to quinolones in Salmonella Typhimurium from patients with infectious diarrhea.Attenuation of in vitro host-pathogen interactions in quinolone-resistant Salmonella Typhi mutants.Absence of TLR11 in Mice Does Not Confer Susceptibility to Salmonella TyphiBiosynthesis of silver nanoparticles using Myristica fragrans seed (nutmeg) extract and its antibacterial activity against multidrug-resistant (MDR) Salmonella enterica serovar Typhi isolates.Azithromycin and ceftriaxone combination treatment for relapsed Salmonella Paratyphi A bacteraemia.Bacteriology: toxins in tandem.Open label comparative trial of mono versus dual antibiotic therapy for Typhoid Fever in adults.Salmonella enterica Serovar Typhi: An Unusual Cause of Infective EndocarditisDevelopment of arginine based nanocarriers for targeting and treatment of intracellular SalmonellaTyphoid Fever Diagnosis in Endemic Countries: A Clog in the Wheel of Progress?
P2860
Q27315926-B30A4D58-0358-4992-8E62-023D538EE890Q27679027-EE76A248-B090-4D36-9896-A94365F3CEFBQ28080658-3D3FD2E6-D79E-471E-8948-E6B5B58BAD0BQ28084595-3E47B996-FFF3-498D-927D-3063B62A8D80Q28482785-370F3775-1AD5-4337-AFC0-A57F748B740AQ34440983-DA8432A0-58CF-4857-9867-F2F3290EB4E7Q34630549-70B03192-AB64-4C91-BC04-6A74E5BEB84DQ34917188-30FCF94E-0E82-4689-A7E8-72C83957D5F4Q35385211-14D146C0-899C-4AE4-9D44-982583F7D3CCQ36133481-CD559A80-C07F-4162-8CFA-42C14CDC893BQ36745856-5AEA624D-41AB-4C55-88C9-A35453238DD7Q37064306-C10DF2F2-83BD-4BCB-A45D-1691E5A30DB9Q37094443-9B0AD5EB-BD91-41A8-9E54-C1B664FF39F8Q37379658-E155EA13-CAD2-444D-8BDB-8B59935055EAQ37583008-61A73D34-18A5-4216-8C75-751F1DF95C9FQ38004886-78F07CC1-29C6-43F1-9F19-F122C6905C99Q38088008-C8837113-6DDF-4970-8FF9-C62344F2C582Q39339429-DD703F33-DEF6-4072-9FDD-AA0C6F96EA06Q40209769-274DFB87-E386-4146-9CAA-5ADF55FF3647Q40280274-45AE275A-2272-4515-825D-F8AAEB57F493Q40962273-EBC8B45E-4FFC-4A13-AB6D-93BC3ACCF5ADQ42398470-71A07CB0-039E-4B92-B6D5-59D5EA359FF4Q47860779-D6EB820E-33E5-41EE-B2B7-09A4276579F9Q49970610-71649419-B054-4D4A-8F69-7860D6070C65Q50014269-77C67B99-4FFA-4AB6-9B05-41DFA0D726AAQ55026157-05F8B8DA-961B-4966-B666-DFB615955405Q57147565-11F3BED2-5A3D-4393-B4B5-6C8773BD9D1CQ57173172-57D84299-E95F-4293-BC4C-229F0C124B56Q57825786-3242245D-0D90-4EDC-8D8E-1179CD716386
P2860
Treatment of typhoid fever in the 21st century: promises and shortcomings.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of typhoid fever in the 21st century: promises and shortcomings.
@en
Treatment of typhoid fever in the 21st century: promises and shortcomings.
@nl
type
label
Treatment of typhoid fever in the 21st century: promises and shortcomings.
@en
Treatment of typhoid fever in the 21st century: promises and shortcomings.
@nl
prefLabel
Treatment of typhoid fever in the 21st century: promises and shortcomings.
@en
Treatment of typhoid fever in the 21st century: promises and shortcomings.
@nl
P1476
Treatment of typhoid fever in the 21st century: promises and shortcomings.
@en
P2093
P304
P356
10.1111/J.1469-0691.2011.03552.X
P577
2011-07-01T00:00:00Z